The April issue of Clinical Lab Products discusses funding awarded from the U.S. Centers for Disease Control and Prevention (CDC) to the College of American Pathologists (CAP). The two grants, totaling more than $1.25 million, will be used to improve the adoption of evidence-based laboratory testing guidelines and to standardize reporting of biomarker test results to cancer registries.
According to Raouf Nakhleh, M.D., a pathologist at the Mayo Clinic in Jacksonville, Fla. who leads CAP's CDC project to improve the impact of laboratory practice guidelines, “By implementing guidelines into clinical practice, hospitals and patients can be assured that the laboratory is following consistent procedures based on scientific evidence and expert consensus opinion.”
CAP develops evidence-based guidelines and consensus recommendations to standardize laboratory practices among the nation’s medical laboratories. To date, the college has released six evidence-based guidelines, including those related to biomarker testing for breast and lung cancer, as well as validation of immunohistochemical assays and whole slide imaging.
Dr. Nakhleh added, “With the CDC grant, we hope to increase awareness for and adoption of the published guidelines, as well as guidelines in development.”